Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2023-05-30 20:56:00 UTC |
---|
HMDB ID | HMDB0000072 |
---|
Secondary Accession Numbers | - HMDB0000461
- HMDB00072
- HMDB00461
|
---|
Metabolite Identification |
---|
Common Name | cis-Aconitic acid |
---|
Description | cis-Aconitic acid, also known as cis-aconitate or acid, acontic, belongs to the class of organic compounds known as tricarboxylic acids and derivatives. These are carboxylic acids containing exactly three carboxyl groups. cis-Aconitic acid exists in all living species, ranging from bacteria to plants to humans. In humans, cis-aconitic acid is involved in the metabolic disorder called the glutaminolysis and cancer pathway. cis-Aconitic acid is a bland tasting compound. cis-Aconitic acid is found, on average, in the highest concentration within milk (cow). cis-Aconitic acid has also been detected, but not quantified in, several different foods, such as french plantains (Musa X paradisiaca), yams (Dioscorea), horseradishes (Armoracia rusticana), sweet potatos (Ipomoea batatas), and persimmons (Diospyros). This could make cis-aconitic acid a potential biomarker for the consumption of these foods. cis-Aconitic acid is a secondary metabolite. Secondary metabolites are metabolically or physiologically non-essential metabolites that may serve a role as defense or signalling molecules. In some cases they are simply molecules that arise from the incomplete metabolism of other secondary metabolites. Based on a literature review a significant number of articles have been published on cis-Aconitic acid. |
---|
Structure | OC(=O)C\C(=C\C(O)=O)C(O)=O InChI=1S/C6H6O6/c7-4(8)1-3(6(11)12)2-5(9)10/h1H,2H2,(H,7,8)(H,9,10)(H,11,12)/b3-1- |
---|
Synonyms | Value | Source |
---|
(Z)-1-Propene-1,2,3-tricarboxylic acid | ChEBI | cis-1-Propene-1,2,3-tricarboxylic acid | ChEBI | (Z)-1-Propene-1,2,3-tricarboxylate | Generator | cis-1-Propene-1,2,3-tricarboxylate | Generator | cis-Aconitate | Generator | (1Z)-1-Propene-1,2,3-tricarboxylate | HMDB | (1Z)-1-Propene-1,2,3-tricarboxylic acid | HMDB | (Z)-Aconitate | HMDB | (Z)-Aconitic acid | HMDB | 1-cis-2,3-Propenetricarboxylate | HMDB | 1-cis-2,3-Propenetricarboxylic acid | HMDB | 1-Propene-1,2,3-tricarboxylate | HMDB | 1-Propene-1,2,3-tricarboxylic acid | HMDB | cis-Aconate | HMDB | cis-Aconic acid | HMDB | cis-Oxaloacetate | HMDB | cis-Oxaloacetic acid | HMDB | Acid, citridic | HMDB | Acid, citridinic | HMDB | Aconitic acid | HMDB | Acontic acid | HMDB | Adonic acid | HMDB | Achilleic acid | HMDB | Acid, acontic | HMDB | Acid, equisetic | HMDB | Citridinic acid | HMDB | Acid, achilleic | HMDB | Aconitate | HMDB | Citridic acid | HMDB | Pyrocitric acid | HMDB | Acid, aconitic | HMDB | Acid, adonic | HMDB | Acid, carboxyglutaconic | HMDB | Acid, pyrocitric | HMDB | Carboxyglutaconic acid | HMDB | Equisetic acid | HMDB |
|
---|
Chemical Formula | C6H6O6 |
---|
Average Molecular Weight | 174.1082 |
---|
Monoisotopic Molecular Weight | 174.016437924 |
---|
IUPAC Name | (1Z)-prop-1-ene-1,2,3-tricarboxylic acid |
---|
Traditional Name | cis-aconitic acid |
---|
CAS Registry Number | 585-84-2 |
---|
SMILES | OC(=O)C\C(=C\C(O)=O)C(O)=O |
---|
InChI Identifier | InChI=1S/C6H6O6/c7-4(8)1-3(6(11)12)2-5(9)10/h1H,2H2,(H,7,8)(H,9,10)(H,11,12)/b3-1- |
---|
InChI Key | GTZCVFVGUGFEME-IWQZZHSRSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as tricarboxylic acids and derivatives. These are carboxylic acids containing exactly three carboxyl groups. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Tricarboxylic acids and derivatives |
---|
Direct Parent | Tricarboxylic acids and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Tricarboxylic acid or derivatives
- Carboxylic acid
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | |
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times UnderivatizedChromatographic Method | Retention Time | Reference |
---|
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 2.35 minutes | 32390414 | Predicted by Siyang on May 30, 2022 | 10.6917 minutes | 33406817 | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 5.12 minutes | 32390414 | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 167.7 seconds | 40023050 | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 949.1 seconds | 40023050 | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 366.4 seconds | 40023050 | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 57.0 seconds | 40023050 | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 213.0 seconds | 40023050 | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 87.9 seconds | 40023050 | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 282.3 seconds | 40023050 | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 310.4 seconds | 40023050 | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 492.9 seconds | 40023050 | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 669.9 seconds | 40023050 | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 131.0 seconds | 40023050 | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1018.7 seconds | 40023050 | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 237.5 seconds | 40023050 | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 284.3 seconds | 40023050 | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 935.7 seconds | 40023050 | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 250.0 seconds | 40023050 | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 554.0 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
cis-Aconitic acid,1TMS,isomer #1 | C[Si](C)(C)OC(=O)C/C(=C/C(=O)O)C(=O)O | 1718.6 | Semi standard non polar | 33892256 | cis-Aconitic acid,1TMS,isomer #2 | C[Si](C)(C)OC(=O)/C=C(/CC(=O)O)C(=O)O | 1699.9 | Semi standard non polar | 33892256 | cis-Aconitic acid,1TMS,isomer #3 | C[Si](C)(C)OC(=O)/C(=C\C(=O)O)CC(=O)O | 1670.3 | Semi standard non polar | 33892256 | cis-Aconitic acid,2TMS,isomer #1 | C[Si](C)(C)OC(=O)/C=C(/CC(=O)O[Si](C)(C)C)C(=O)O | 1780.3 | Semi standard non polar | 33892256 | cis-Aconitic acid,2TMS,isomer #2 | C[Si](C)(C)OC(=O)C/C(=C/C(=O)O)C(=O)O[Si](C)(C)C | 1742.9 | Semi standard non polar | 33892256 | cis-Aconitic acid,2TMS,isomer #3 | C[Si](C)(C)OC(=O)/C=C(/CC(=O)O)C(=O)O[Si](C)(C)C | 1722.5 | Semi standard non polar | 33892256 | cis-Aconitic acid,3TMS,isomer #1 | C[Si](C)(C)OC(=O)/C=C(/CC(=O)O[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1745.8 | Semi standard non polar | 33892256 | cis-Aconitic acid,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C/C(=C/C(=O)O)C(=O)O | 1965.7 | Semi standard non polar | 33892256 | cis-Aconitic acid,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)/C=C(/CC(=O)O)C(=O)O | 1950.7 | Semi standard non polar | 33892256 | cis-Aconitic acid,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC(=O)/C(=C\C(=O)O)CC(=O)O | 1943.6 | Semi standard non polar | 33892256 | cis-Aconitic acid,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)/C=C(/CC(=O)O[Si](C)(C)C(C)(C)C)C(=O)O | 2263.6 | Semi standard non polar | 33892256 | cis-Aconitic acid,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)C/C(=C/C(=O)O)C(=O)O[Si](C)(C)C(C)(C)C | 2205.9 | Semi standard non polar | 33892256 | cis-Aconitic acid,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC(=O)/C=C(/CC(=O)O)C(=O)O[Si](C)(C)C(C)(C)C | 2172.6 | Semi standard non polar | 33892256 | cis-Aconitic acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)/C=C(/CC(=O)O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2399.3 | Semi standard non polar | 33892256 |
|
---|
Disease References | Alzheimer's disease |
---|
- Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013 Sep 6. [PubMed:23857558 ]
| Frontotemporal dementia |
---|
- Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013 Sep 6. [PubMed:23857558 ]
| Lewy body disease |
---|
- Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013 Sep 6. [PubMed:23857558 ]
| Lung Cancer |
---|
- Wishart DS, Knox C, Guo AC, Eisner R, Young N, Gautam B, Hau DD, Psychogios N, Dong E, Bouatra S, Mandal R, Sinelnikov I, Xia J, Jia L, Cruz JA, Lim E, Sobsey CA, Shrivastava S, Huang P, Liu P, Fang L, Peng J, Fradette R, Cheng D, Tzur D, Clements M, Lewis A, De Souza A, Zuniga A, Dawe M, Xiong Y, Clive D, Greiner R, Nazyrova A, Shaykhutdinov R, Li L, Vogel HJ, Forsythe I: HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 2009 Jan;37(Database issue):D603-10. doi: 10.1093/nar/gkn810. Epub 2008 Oct 25. [PubMed:18953024 ]
| Eosinophilic esophagitis |
---|
- Slae, M., Huynh, H., Wishart, D.S. (2014). Analysis of 30 normal pediatric urine samples via NMR spectroscopy (unpublished work). NA.
| Schizophrenia |
---|
- Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C: Potential metabolite markers of schizophrenia. Mol Psychiatry. 2013 Jan;18(1):67-78. doi: 10.1038/mp.2011.131. Epub 2011 Oct 25. [PubMed:22024767 ]
| Amish lethal microcephaly |
---|
- Kelley RI, Robinson D, Puffenberger EG, Strauss KA, Morton DH: Amish lethal microcephaly: a new metabolic disorder with severe congenital microcephaly and 2-ketoglutaric aciduria. Am J Med Genet. 2002 Nov 1;112(4):318-26. doi: 10.1002/ajmg.10529. [PubMed:12376931 ]
|
|
---|
General References | - Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009 Feb 12;457(7231):910-4. doi: 10.1038/nature07762. [PubMed:19212411 ]
- Boulat O, Gradwohl M, Matos V, Guignard JP, Bachmann C: Organic acids in the second morning urine in a healthy Swiss paediatric population. Clin Chem Lab Med. 2003 Dec;41(12):1642-58. [PubMed:14708889 ]
- Guneral F, Bachmann C: Age-related reference values for urinary organic acids in a healthy Turkish pediatric population. Clin Chem. 1994 Jun;40(6):862-6. [PubMed:8087979 ]
- Swart PJ, Kuipers EM, Smit C, Van Der Strate BW, Harmsen MC, Meijer DK: Lactoferrin. Antiviral activity of lactoferrin. Adv Exp Med Biol. 1998;443:205-13. [PubMed:9781360 ]
- Stromme JH, Borud O, Moe PJ: Fatal lactic acidosis in a newborn attributable to a congenital defect of pyruvate dehydrogenase. Pediatr Res. 1976 Jan;10(1):62-6. [PubMed:813176 ]
- Redjems-Bennani N, Jeandel C, Lefebvre E, Blain H, Vidailhet M, Gueant JL: Abnormal substrate levels that depend upon mitochondrial function in cerebrospinal fluid from Alzheimer patients. Gerontology. 1998;44(5):300-4. [PubMed:9693263 ]
- Swart PJ, Kuipers ME, Smit C, Pauwels R, deBethune MP, de Clercq E, Meijer DK, Huisman JG: Antiviral effects of milk proteins: acylation results in polyanionic compounds with potent activity against human immunodeficiency virus types 1 and 2 in vitro. AIDS Res Hum Retroviruses. 1996 Jun 10;12(9):769-75. [PubMed:8738428 ]
- Matsuishi T, Urabe F, Percy AK, Komori H, Yamashita Y, Schultz RS, Ohtani Y, Kuriya N, Kato H: Abnormal carbohydrate metabolism in cerebrospinal fluid in Rett syndrome. J Child Neurol. 1994 Jan;9(1):26-30. [PubMed:8151077 ]
|
---|